Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176K Sell
535
-7
-1% -$2.5K 0.02% 79
2025
Q4
$190K Buy
542
+30
+6% +$9.52K 0.02% 66
2025
Q3
$155K Hold
512
0.02% 68
2025
Q2
$152K Buy
+512
New +$145K 0.02% 68

Other funds holding AMGN

RMG Wealth Management's AMGN Position: Q1 2026 in Review

RMG Wealth Management reduced its Amgen (AMGN) stake by 1.3% in Q1 2026, selling an estimated $2.5K and leaving 535 shares worth $176K. The position accounts for 0.02% of the portfolio, ranked #79.

RMG Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. The position peaked at $190K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • RMG Wealth Management held 535 shares of Amgen worth $176K as of Q1 2026.
  • RMG Wealth Management sold 7 Amgen shares in Q1 2026, an estimated $2.5K.
  • Amgen made up 0.02% of RMG Wealth Management's portfolio in Q1 2026, its #79 holding.
  • RMG Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • RMG Wealth Management's Amgen position peaked at $190K in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on RMG Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.